These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 3434050)
61. [Effect of multiple vaccination against influenza on the specificity of humoral immunity]. Iagodovskiĭ VV; Slepushkin AN; Schastnyĭ EI; Fedorova GI Vopr Virusol; 1986; 31(3):300-3. PubMed ID: 3765556 [TBL] [Abstract][Full Text] [Related]
62. Safety and immunogenicity of a recombinant protein influenza A vaccine in adult human volunteers and protective efficacy against wild-type H1N1 virus challenge. Fries LF; Dillon SB; Hildreth JE; Karron RA; Funkhouser AW; Friedman CJ; Jones CS; Culleton VG; Clements ML J Infect Dis; 1993 Mar; 167(3):593-601. PubMed ID: 8440931 [TBL] [Abstract][Full Text] [Related]
64. A prospective, randomized, open-label trial comparing the safety and efficacy of trivalent live attenuated and inactivated influenza vaccines in adults 60 years of age and older. Forrest BD; Steele AD; Hiemstra L; Rappaport R; Ambrose CS; Gruber WC Vaccine; 2011 May; 29(20):3633-9. PubMed ID: 21440036 [TBL] [Abstract][Full Text] [Related]
65. Attenuated influenza A viruses with modified cleavage sites in hemagglutinin as live vaccines. Stech J Expert Rev Vaccines; 2008 Aug; 7(6):739-43. PubMed ID: 18665773 [TBL] [Abstract][Full Text] [Related]
66. [Influenza vaccine stimulation of antibodies to different variants of influenza A virus]. Naĭkhin AN; Ispolatova AV; Tsybul'skaia NV; Sominina AA; Denisov GM Vopr Virusol; 1985; 30(3):290-6. PubMed ID: 4049840 [TBL] [Abstract][Full Text] [Related]
67. Comparison of Adjuvanted-Whole Inactivated Virus and Live-Attenuated Virus Vaccines against Challenge with Contemporary, Antigenically Distinct H3N2 Influenza A Viruses. Abente EJ; Rajao DS; Santos J; Kaplan BS; Nicholson TL; Brockmeier SL; Gauger PC; Perez DR; Vincent AL J Virol; 2018 Nov; 92(22):. PubMed ID: 30185589 [TBL] [Abstract][Full Text] [Related]
68. Further researches on live influenza virus vaccines. De Barbieri A; Crovari P; Cuneo-Crovari P; Giacometti G Dev Biol Stand; 1977 Jun 1-3; 39():73-6. PubMed ID: 604136 [TBL] [Abstract][Full Text] [Related]
69. Dynamics of neutralizing secretory influenza antibodies after nasal administration of the NIVGRIP trivalent influenza vaccine. Petrescu A; Steiner N; Trăilescu G; Teodosiu O; Mihăilescu M; Berca C Virologie; 1985; 36(3):187-94. PubMed ID: 4071977 [TBL] [Abstract][Full Text] [Related]
70. Effective immunization with live attenuated influenza A virus can be achieved in early infancy. Pediatric Care Center. Clements ML; Makhene MK; Karron RA; Murphy BR; Steinhoff MC; Subbarao K; Wilson MH; Wright PF J Infect Dis; 1996 Jan; 173(1):44-51. PubMed ID: 8537681 [TBL] [Abstract][Full Text] [Related]
71. The specificity of the anti-haemagglutinin antibody response induced in man by inactivated influenza vaccines and by natural infection. Oxford JS; Schild GC; Potter CW; Jennings R J Hyg (Lond); 1979 Feb; 82(1):51-61. PubMed ID: 105040 [TBL] [Abstract][Full Text] [Related]
72. Live attenuated influenza vaccine is safe and immunogenic in immunocompromised ferrets. Huber VC; McCullers JA J Infect Dis; 2006 Mar; 193(5):677-84. PubMed ID: 16453263 [TBL] [Abstract][Full Text] [Related]
73. Study of live recombinant cold-adapted influenza bivalent vaccine of type A for use in children: an epidemiological control trial. Alexandrova GI; Budilovsky GN; Koval TA; Polezhaev FI; Garmashova LM; Ghendon YuZ ; Romanova YR; Smorodintsev AA Vaccine; 1986 Jun; 4(2):114-8. PubMed ID: 3524050 [TBL] [Abstract][Full Text] [Related]
74. [Characteristics of the immune response in children multiply inoculated with an inactivated influenza vaccine]. Rudenko LG; Vasil'eva RI; Smirnova LA; Doroshenko EM Vopr Virusol; 1988; 33(4):407-11. PubMed ID: 3195142 [TBL] [Abstract][Full Text] [Related]
75. Influenza A virus vaccines containing purified recombinant H3 hemagglutinin are well tolerated and induce protective immune responses in healthy adults. Powers DC; Smith GE; Anderson EL; Kennedy DJ; Hackett CS; Wilkinson BE; Volvovitz F; Belshe RB; Treanor JJ J Infect Dis; 1995 Jun; 171(6):1595-9. PubMed ID: 7769297 [TBL] [Abstract][Full Text] [Related]
76. [Biological properties of live and inactivated influenza vaccines under experimental conditions]. Bozhenko LV; Agafonova LM; Konstantinova II; Shefer LF; Kustikova IuG Vopr Virusol; 1983; (2):187-91. PubMed ID: 6868558 [TBL] [Abstract][Full Text] [Related]
77. E-rosette forming cells and humoral antibody titres in humans after vaccination with three different inactivated influenza virus vaccines A/USSR/92/77 (H1N1). Schmidt S; Süss J; Oehring H; Schmidt J Acta Virol; 1982 Dec; 26(6):466-73. PubMed ID: 6132540 [TBL] [Abstract][Full Text] [Related]
78. [Inoculation properties of a pediatric variant of adsorbed influenza chemical vaccine]. Berdnikova LF; Vasiaev AI; Pushkarev MA; Vlasov AR; D'iakonova LG Zh Mikrobiol Epidemiol Immunobiol; 1987 Nov; (11):48-52. PubMed ID: 3434049 [TBL] [Abstract][Full Text] [Related]